Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OPGMW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Recombinant chimeric anti-CD30 mAb-MCC-DM1
|
|||||
| Organization |
Shanghai Jiaolian Drug Development Co. Ltd.; Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.; Shanghai Pharmaceutical (Group) Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||